Design and synthesis of quinazoline derivatives as novel JMJD3/HDAC dual-target inhibitors
RSC Medicinal Chemistry · 2026 · 17 (8) · 3703-3723
DOI: 10.1039/d6md00427j ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Liwei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Yunna…. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Structural optimization yields 6a as a potent dual JMJD3/HDAC inhibitor, which suppresses proliferation and induces cell cycle arrest in TNBC cells.
Autor:innen und Institutionen
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Characteristic Plant Extraction Laboratory Co., Ltd., Yunnan Key Laboratory of Research and Development for Natural Products, Sch…
- School of Chinese Materia Medicine, Yunnan University of Chinese Medicine Kunming Yunnan 650500 China huizipurple@163.com.
ORCID-Profile: Ruihan Zhang, Weilie Xiao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Zhang, Y., Chen, K., Liu, Y., Zhang, X., Xu, G., Ni, D., Zhang, X., Zhang, R., Chen, C. H., & Xiao, W. (2026). Design and synthesis of quinazoline derivatives as novel JMJD3/HDAC dual-target inhibitors. RSC Medicinal Chemistry, 17(8), 3703-3723. https://doi.org/10.1039/d6md00427j
Vancouver
Wang L, Zhang Y, Chen K, Liu Y, Zhang X, Xu G, et al. Design and synthesis of quinazoline derivatives as novel JMJD3/HDAC dual-target inhibitors. RSC Medicinal Chemistry. 2026;17(8):3703-3723. doi:10.1039/d6md00427j
BibTeX
@article{Wang2026,
author = {Wang, Liwei and Zhang, Yuke and Chen, Ketong and Liu, Yunlin and Zhang, Xian and Xu, Guanfei and Ni, Dongxuan and Zhang, Xingjie and Zhang, Ruihan and Chen, Chuan-Huizi and Xiao, Weilie},
title = {Design and synthesis of quinazoline derivatives as novel JMJD3/HDAC dual-target inhibitors},
journal = {RSC Medicinal Chemistry},
year = {2026},
volume = {17},
number = {8},
pages = {3703--3723},
doi = {10.1039/d6md00427j}
}
EUVIMED